XML 25 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2019 37,267,000        
Beginning balance at Dec. 31, 2019 $ 134,720        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Issuance of Series C convertible preferred stock, net of issuance costs (in shares) 538,000        
Issuance of Series C convertible preferred stock, net of issuance costs $ 2,200        
Conversion of convertible preferred stock into common stock upon completion of initial public offering (in shares) (37,805,000)        
Conversion of convertible preferred stock into common stock upon completion of initial public offering $ (136,920)        
Ending balance (in shares) at Dec. 31, 2020 0        
Ending balance at Dec. 31, 2020 $ 0        
Beginning balance (in shares) at Dec. 31, 2019   2,989,000      
Beginning balance at Dec. 31, 2019 (65,357) $ 0 $ (43,172) $ 0 $ (22,185)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in initial public offering, net of issuance costs (in shares)   16,560,000      
Issuance of common stock in initial public offering, net of issuance costs 274,054 $ 2 274,052    
Conversion of convertible preferred stock into common stock upon completion of initial public offering (in shares)   17,921,000      
Conversion of convertible preferred stock into common stock upon completion of initial public offering 136,920 $ 2 136,918    
Reclassification of warrant liability to equity due to adjustment from preferred stock warrant to common stock warrant upon completion of initial public offering 120   120    
Cashless exercise of common stock warrants (in shares)   16,000      
Issuance of common stock upon exercise of stock options (in shares)   54,000      
Issuance of common stock upon exercise of stock options 22   22    
Issuance of common stock under employee stock purchase plan (in shares)   29,000      
Issuance of common stock under employee stock purchase plan 444   444    
Vesting of early exercise options 70   70    
Stock-based compensation 4,310   4,310    
Net loss (44,355)       (44,355)
Other comprehensive loss (5)     (5)  
Ending balance (in shares) at Dec. 31, 2020   37,569,000      
Ending balance at Dec. 31, 2020 $ 306,223 $ 4 372,764 (5) (66,540)
Ending balance (in shares) at Dec. 31, 2021 0        
Ending balance at Dec. 31, 2021 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in initial public offering, net of issuance costs (in shares)   9,980,000      
Issuance of common stock in initial public offering, net of issuance costs 174,677 $ 1 174,676    
Issuance of common stock upon exercise of stock options (in shares)   172,000      
Issuance of common stock upon exercise of stock options 930   930    
Issuance of common stock under employee stock purchase plan (in shares)   33,000      
Issuance of common stock under employee stock purchase plan 709   709    
Vesting of early exercise options 26   26    
Stock-based compensation 17,056   17,056    
Net loss (118,009)       (118,009)
Other comprehensive loss $ (182)     (182)  
Ending balance (in shares) at Dec. 31, 2021 47,754,000 47,754,000      
Ending balance at Dec. 31, 2021 $ 381,430 $ 5 566,161 (187) (184,549)
Ending balance (in shares) at Dec. 31, 2022 0        
Ending balance at Dec. 31, 2022 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in initial public offering, net of issuance costs (in shares)   21,572,000      
Issuance of common stock in initial public offering, net of issuance costs $ 344,616 $ 2 344,614    
Issuance of common stock upon exercise of stock options (in shares) 351,000 351,000      
Issuance of common stock upon exercise of stock options $ 470   470    
Issuance of common stock under employee stock purchase plan (in shares)   91,000      
Issuance of common stock under employee stock purchase plan 922   922    
Vesting of early exercise options 4   4    
Stock-based compensation 27,139   27,139    
Net loss (173,995)       (173,995)
Other comprehensive loss $ (2,511)     (2,511)  
Ending balance (in shares) at Dec. 31, 2022 69,768,000 69,768,000      
Ending balance at Dec. 31, 2022 $ 578,075 $ 7 $ 939,310 $ (2,698) $ (358,544)